Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Progestogens for Prevention of Preterm Birth

Slide: 21 of 29

Summary of Benefits: According to Indication/Risk Group (2 of 3)

Women with short cervix may benefit from progestogen treatment, but the size of the effect is not established. The strength of evidence for this conclusion is low.

In women with twin or triplet pregnancies there is no benefit of progestogen treatment. Moderate-strength evidence indicates that birth is not delayed. Moderate-strength evidence indicates that birth weights are not improved. The evidence about mortality rates is insufficient to permit a summary estimate of the effect.